Summary
The goal of STRATIFY was to validate a novel autoantibody to serve as a diagnostic test in aplastic anemia, which is a rare hematological autoimmune disease. We analyzed a cohort of over 400 patients with aplastic anemia, together with a control cohort of more than 800 plasma...